Denise Yardley, MD, Tennessee Oncology
Advertisement
Articles by Denise Yardley, MD, Tennessee Oncology
Advertisement
Latest Updated Articles
Dr. Yardley on Endocrine Therapy Plus CDK4/6 Inhibitors in Breast Cancer With Visceral MetastasesPublished: August 17th 2020 | Updated:
Dr. Yardley on tNACity Trial for Triple-Negative Breast CancerPublished: January 12th 2017 | Updated:
Dr. Yardley on the APHINITY Trial for HER2-Positive Breast CancerPublished: June 20th 2017 | Updated:
Dr. Yardley on the Results of the APT and APHINITY Trials for HER2+ Breast CancerPublished: July 7th 2017 | Updated:
Dr. Yardley Shares Insight on the Impact of BiosimilarsPublished: August 29th 2018 | Updated:
Dr. Yardley on the RESPECT Trial in HER2-Positive Breast CancerPublished: September 15th 2018 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Single-Center, Retrospective Data Show Low Rate of Lifileucel Infusion Following Referral in Advanced Melanoma
2
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
3
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
4
Dr Riedell on the Long-Term Efficacy of Tisa-Cel in R/R Follicular Lymphoma
5